Patient Care

Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™

ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond™, is designed to provide multiple levels of protection PRINCETON, N.J., March 3, 2025...

Retrieve Medical, Inc. Emphasizes Proactive Compliance Amidst Upcoding Scrutiny: Our Patent Pending Preprocessor has Multi-billion Dollar Market Potential

BEDMINSTER, N.J., Feb. 28, 2025 /PRNewswire/ -- In light of recent reports regarding investigations into Medicare Advantage billing practices, Retrieve...

error: Content is protected !!